Inventor
Ning Qi
Inventor
Hamden, CT, US
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes11%
C12NMicroorganisms or enzymes6%
B41MPrinting, duplicating, marking, or copying processes3%
B42DBooks3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C08LCompositions of macromolecular compounds3%
C09DCoating compositions, e.g. paints, varnishes or lacquers3%
C23CCoating metallic material3%
PatentTitleYear
11,109,191Method for displaying current geographical location on emergency call screen and terminal202110,857,830Silk fibroin-based optical anti-counterfeiting mark and preparation method thereof202010,450,335Antiviral oxime phosphoramide compounds20199,512,426'Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications'20168,877,439'Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications'20148,138,336'Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase'20127,517,878'Heteroarylaminopyrazole derivatives useful for the treatment of diabetes'20097,265,144'Anilinopyrazole derivatives useful for the treatment of diabetes'20077,109,196'1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders'20066,919,371'2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'20056,900,205'1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders'20056,787,651'Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR- binding agents'20046,660,752'2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2007Patents assigned to BAYER PHARMACEUTICALS CORP (5)· patent assignee history
2003–2009Based in Hamden, CT, US· patent location history
2009Patents assigned to BAYER PHARAMCEUTICALS CORP (1)· patent assignee history
2012–2014Patents assigned to QI NING (2)· patent assignee history
2012Patents assigned to BAYER HEALTHCARE LLC (1)· patent assignee history
2012–2016Based in Rahway, NJ, US· patent location history
2014–2016Patents assigned to SIRNA THERAPEUTICS INC (2)· patent assignee history
2019Based in Somerset, NJ, US· patent location history
2020Based in Nantong, CN· patent location history
2021Based in Beijing, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAYER PHARMACEUTICALS CORP | 5 | 2003–2007 |
| QI NINGself | 2 | 2012–2014 |
| SIRNA THERAPEUTICS INC | 2 | 2014–2016 |
| BAYER HEALTHCARE LLC | 1 | 2012 |
| BAYER PHARAMCEUTICALS CORP | 1 | 2009 |
Locations
| Location | Patents | Span |
|---|---|---|
| Hamden, CT, US | 7 | 2003–2009 |
| Rahway, New Jersey, US | 3 | 2012–2016 |
| Beijing, CN | 1 | 2021 |
| Nantong, CN | 1 | 2020 |
| Somerset, New Jersey, US | 1 | 2019 |